💨 Abstract

US lawmakers and industry leaders are urging stricter export controls on US biopharmaceutical companies collaborating with China's military, citing concerns over China's strategic efforts to advance biotech capabilities. The proposed regulations aim to prevent US technology from being used for military and intelligence purposes by PLA medical institutions.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖